Research programme: anti-DNA damage agents - DNage

Drug Profile

Research programme: anti-DNA damage agents - DNage

Alternative Names: Anti-DNA-damage-agents; DNA repair agents - DNage

Latest Information Update: 02 Feb 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator DNage
  • Class Small molecules
  • Mechanism of Action Antioxidants; Free radical scavengers; Oxygen radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Metabolic disorders; Neurodegenerative disorders; Osteoporosis

Most Recent Events

  • 31 Jan 2011 Discontinued - Preclinical for Metabolic disorders in Netherlands (PO)
  • 31 Jan 2011 Discontinued - Preclinical for Neurodegenerative disorders in Netherlands (PO)
  • 31 Jan 2011 Discontinued - Preclinical for Osteoporosis in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top